## Distinguishing PCV from Hib in IAP Schedule ### Pneumococcal Conjugate Vaccine (PCV) Schedule **Key Point:** PCV follows a 3+1 schedule with the booster administered earlier than Hib. - Primary series: 3 doses at 6, 10, 14 weeks - Booster dose: 12–15 months (second year of life) - Total: 4 doses - Protects against 13 serotypes of *Streptococcus pneumoniae* ### Haemophilus influenzae type b (Hib) Vaccine Schedule **Key Point:** Hib also follows a 3+1 schedule but with a later booster timing. - Primary series: 3 doses at 6, 10, 14 weeks - Booster dose: 18–24 months (second year of life, but later than PCV) - Total: 4 doses - Protects against *Haemophilus influenzae* type b only ### Comparison Table | Feature | PCV | Hib | |---------|-----|-----| | **Primary doses** | 3 (at 6, 10, 14 weeks) | 3 (at 6, 10, 14 weeks) | | **Booster timing** | 12–15 months | 18–24 months | | **Total doses** | 4 | 4 | | **Serotypes covered** | 13 | 1 | | **Route** | Intramuscular | Intramuscular | | **Catch-up schedule** | Yes (up to 5 years) | Yes (up to 5 years) | **High-Yield:** The most practical discriminator in the IAP schedule is the booster timing: PCV booster at 12–15 months vs. Hib booster at 18–24 months. This is a high-yield fact for exam questions. **Mnemonic:** **PCV-EARLY, Hib-LATE** — PCV booster comes earlier (12–15 months) than Hib booster (18–24 months). **Clinical Pearl:** Both are conjugate vaccines and both require 4 total doses, but the staggered booster schedule allows for separate administration windows and reduces the injection load at any single visit. [cite:IAP 2023 Immunisation Guidelines]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.